04:31 PM EDT, 09/09/2025 (MT Newswires) -- Troy Edward Wilson, Director, President & CEO, on September 08, 2025, executed a purchase for 50,000 shares in Kura Oncology ( KURA ) for $410,145. Following the Form 4 filing with the SEC, Wilson has control over a total of 680,162 common shares of the company, with 100,968 shares held directly and 579,194 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1422143/000141588925023974/xslF345X05/form4-09092025_080937.xml